Reproductive Health in the Trump Era: Implications of Recent Federal and Judicial Action
Proposed Changes to Title X: Implications for Women and Family Planning Providers
New Regulations Broadening Employer Exemptions to Contraceptive Coverage: Impact on Women
Coverage for Abortion Services in Medicaid, Marketplace Plans and Private Plans
See national and state estimates on the availability of abortion coverage for women enrolled in private plans, Marketplace plans and Medicaid.
New Title X Regulations: Implications for Women and Family Planning Providers
>Alina Salganicoff Answers 3 Questions on Final Title X Regulations for Family Planning Clinics
Potential Impact of Proposed Regulations on Abortion Coverage in Marketplace Plans
The day after the 2018 midterm elections, the Trump Administration issued proposed regulations that would require ACA Marketplace plans to issue separate bills to individuals who have abortion coverage as part of their benefit package.
The Myth Of The Abortion Insurance Rider
In Health Affairs, KFF experts discuss the feasibility of abortion riders to private group and individual health plans as a means of providing access to abortion coverage when states ban the coverage as part of an insurance plan.
Abortion Riders in States with Insurance Restrictions
- 10 states ban abortion coverage in most private plans
- 9 of these states allow sale of abortion riders
- No insurers offer abortion riders on individual market in these states
Changes to Contraceptive Coverage Rule: Exemptions & Accommodations
- Which employers are exempt from providing contraceptive coverage without cost sharing.
- What type of employers may seek an “accommodation” to avoid paying for contraceptives in their plans.
Medicaid’s Role for Women
Changes to the program’s financing and structure could have significant implications for low-income women’s access to coverage and care.
Fact Sheet: Medication Abortion
Even as overall rates of abortion decline, the use of medication abortion has grown significantly since its approval by the FDA.
Interactive
State Profiles for Women’s Health
